Covid-19 Innovation Challenges by Innoget

Using Signature Genes to Detect Early-Stage Coronavirus and Predict Individual Outcomes

Posted by Covid-19 Innovation Challenges by InnogetVery responsive · Innovative Products and Technologies · United Kingdom

Summary of the technology

Using Signature Genes to Detect Early-Stage Coronavirus and Predict Individual Outcomes
Project ID : 47-2020-10876

Test signature genes of host for non-invasive and early detection of Coronavirus infection, even before the infected person is symptomatic (also allowing differentiation from influenza virus infections).

Moreover, this unique signature can be used to predict disease outcome in infected individuals as well as predict the vulnerability to the virus in non- infected individuals. The last can be valuable for screening of vulnerable populations such as medical teams and caregivers.

Covid-19 Innovation Challenges by Innoget

Description of the technology

  • Test signature genes of host for non-invasive and early detection of Coronavirus infection, even before the infected person is symptomatic (also allowing differentiation from influenza virus infections).
  • Moreover, this unique signature can be used to predict disease outcome in infected individuals as well as predict the vulnerability to the virus in non- infected individuals. The last can be valuable for screening of vulnerable populations such as medical teams and caregivers.

Project manager

Mel Larrosa
VP Business Development Healthcare

Project researchers

Yoav Smith
HUJI, School of Medicine - IMRIC

Technology Owner

Covid-19 Innovation Challenges by Innoget

Innovation Intermediary

Related keywords

  • Electronics, IT and Telecomms
  • Computer Software Technology
  • Electronic Signature
  • Cyber Security
  • Electronics Related Market
  • Covid-19
  • coronavirus

About Covid-19 Innovation Challenges by Innoget

Innovation Intermediary from United Kingdom

Ahead of the current Coronavirus outbreak, Innoget is fully committed to contributing to mobilizing scientific and expert communities to find a real solution to the Covid-19 pandemic. Therefore, we're supporting worldwide calls and programs that could help in any aspects of the coronavirus crisis.

Is your organization promoting or looking for innovation or research initiatives to mitigate the Covid-19 outbreak? Email us at covid19@innoget.com to list them.

Channeled through Innoget's online open innovation network, initiatives in the health, virology, medicine, or novel technologies applied to human health, among others, are listed and disseminated to Innoget members -ranging from hospitals, research institutes, scientists, businesses, and public administrations- and innovation partners worldwide.